Allergy Therapeutics plc (AIM:AGY)
8.40
0.00 (0.00%)
Aug 15, 2025, 4:35 PM GMT+1
Allergy Therapeutics Market Cap
Allergy Therapeutics has a market cap or net worth of 400.38 million as of August 15, 2025. Its market cap has increased by 78.34% in one year.
Market Cap
400.38M
Enterprise Value
423.22M
Revenue
55.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.40
Market Cap Chart
Since October 11, 2004, Allergy Therapeutics's market cap has increased from 30.57M to 400.38M, an increase of 1,209.74%. That is a compound annual growth rate of 13.13%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 400.38M | 29.23% |
Dec 31, 2024 | 309.82M | 160.00% |
Dec 29, 2023 | 119.16M | 180.75% |
Dec 30, 2022 | 42.44M | -79.49% |
Dec 31, 2021 | 206.98M | 94.57% |
Dec 31, 2020 | 106.38M | 63.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 179.76B |
GSK plc | 57.45B |
Haleon | 31.97B |
Smith & Nephew | 11.74B |
ConvaTec Group | 4.66B |
Hikma Pharmaceuticals | 3.97B |
HUTCHMED (China) | 2.09B |
Oxford Nanopore Technologies | 2.02B |